+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Anti-Mullerian Hormone Test Market Research Report by Product, End-User, Distribution, Use, Country - North America Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 149 Pages
  • October 2022
  • Region: North America
  • 360iResearch™
  • ID: 5667280
UP TO OFF until Mar 31st 2023
The North America Anti-Mullerian Hormone Test Market size was estimated at USD 67.87 million in 2021, USD 74.89 million in 2022, and is projected to grow at a CAGR of 11.08% to reach USD 127.52 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Anti-Mullerian Hormone Test to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across POC Testing and Self-check Kits. The Self-check Kits is further studied across ELISA Kits and Rapid Test Kit.
  • Based on End-User, the market was studied across Commercial Labs and Research & development.
  • Based on Distribution, the market was studied across Offline Channels and Online Channels.
  • Based on Use, the market was studied across Human and Non-Human.
  • Based on Country, the market was studied across Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Anti-Mullerian Hormone Test market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Anti-Mullerian Hormone Test Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the North America Anti-Mullerian Hormone Test Market, including Abbexa Ltd., Ansh Labs, BioMérieux SA, CTK Biotech, Inc., Cusabio Technology LLC, Danaher Corporation, Doctorcall Limited, Eagle Biosciences, Inc., Elabscience, Inc., enQuire Bio, LLC, F. Hoffmann-La Roche AG, Fertility 2 U Ltd, Kamiya Biomedical Co, LifeSpan BioSciences, Inc., London Gynaecology Ltd., Monobind Inc., Tosoh Corporation, and Walk-In Lab, LLC.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the North America Anti-Mullerian Hormone Test Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the North America Anti-Mullerian Hormone Test Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the North America Anti-Mullerian Hormone Test Market?
4. What is the competitive strategic window for opportunities in the North America Anti-Mullerian Hormone Test Market?
5. What are the technology trends and regulatory frameworks in the North America Anti-Mullerian Hormone Test Market?
6. What is the market share of the leading vendors in the North America Anti-Mullerian Hormone Test Market?
7. What modes and strategic moves are considered suitable for entering the North America Anti-Mullerian Hormone Test Market?


This product will be delivered within 2 business days.
Frequently Asked Questions about the North American Anti-Mullerian Hormone Test Market

What is the estimated value of the North American Anti-Mullerian Hormone Test Market?

The North American Anti-Mullerian Hormone Test Market was estimated to be valued at $67.87 Million in 2021.

What is the growth rate of the North American Anti-Mullerian Hormone Test Market?

The growth rate of the North American Anti-Mullerian Hormone Test Market is 11.0%, with an estimated value of $127.52 Million by 2027.

What is the forecasted size of the North American Anti-Mullerian Hormone Test Market?

The North American Anti-Mullerian Hormone Test Market is estimated to be worth $127.52 Million by 2027.

Who are the key companies in the North American Anti-Mullerian Hormone Test Market?

Key companies in the North American Anti-Mullerian Hormone Test Market include Abbexa Ltd., Ansh Labs, BioMérieux SA, CTK Biotech, Inc., Cusabio Technology LLC, Danaher Corporation, Doctorcall Limited, Eagle Biosciences, Inc. and enQuire Bio, LLC.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Anti-Mullerian Hormone Test Market, by Product
6.1. Introduction
6.2. POC Testing
6.3. Self-check Kits
6.4.1. ELISA Kits
6.4.2. Rapid Test Kit
7. Anti-Mullerian Hormone Test Market, by End-User
7.1. Introduction
7.2. Commercial Labs
7.3. Research & development
8. Anti-Mullerian Hormone Test Market, by Distribution
8.1. Introduction
8.2. Offline Channels
8.3. Online Channels
9. Anti-Mullerian Hormone Test Market, by Use
9.1. Introduction
9.2. Human
9.3. Non-Human
10. Canada Anti-Mullerian Hormone Test Market
10.1. Introduction
11. Mexico Anti-Mullerian Hormone Test Market
11.1. Introduction
12. United States Anti-Mullerian Hormone Test Market
12.1. Introduction
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Abbexa Ltd.
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Ansh Labs
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. BioMérieux SA
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. CTK Biotech, Inc.
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Cusabio Technology LLC
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Danaher Corporation
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Doctorcall Limited
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Eagle Biosciences, Inc.
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Elabscience, Inc.
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. enQuire Bio, LLC
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. F. Hoffmann-La Roche AG
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Fertility 2 U Ltd
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Kamiya Biomedical Co
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. LifeSpan BioSciences, Inc.
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. London Gynaecology Ltd.
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Monobind Inc.
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Tosoh Corporation
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Walk-In Lab, LLC
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET: RESEARCH PROCESS
FIGURE 2. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2021 VS 2027
FIGURE 3. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 5. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 6. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 7. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET DYNAMICS
FIGURE 8. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 9. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 10. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2027
FIGURE 11. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY POC TESTING, 2018-2027 (USD MILLION)
FIGURE 12. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2027 (USD MILLION)
FIGURE 13. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY ELISA KITS, 2018-2027 (USD MILLION)
FIGURE 14. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY RAPID TEST KIT, 2018-2027 (USD MILLION)
FIGURE 15. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 16. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
FIGURE 17. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2027
FIGURE 18. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMMERCIAL LABS, 2018-2027 (USD MILLION)
FIGURE 19. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2027 (USD MILLION)
FIGURE 20. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (%)
FIGURE 21. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (USD MILLION)
FIGURE 22. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET COMPETITIVE STRATEGIC WINDOW, BY DISTRIBUTION, 2027
FIGURE 23. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY OFFLINE CHANNELS, 2018-2027 (USD MILLION)
FIGURE 24. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY ONLINE CHANNELS, 2018-2027 (USD MILLION)
FIGURE 25. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2021 VS 2027 (%)
FIGURE 26. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2021 VS 2027 (USD MILLION)
FIGURE 27. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET COMPETITIVE STRATEGIC WINDOW, BY USE, 2027
FIGURE 28. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY HUMAN, 2018-2027 (USD MILLION)
FIGURE 29. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY NON-HUMAN, 2018-2027 (USD MILLION)
FIGURE 30. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 31. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 32. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 33. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 34. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 35. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 36. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 37. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 38. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 5. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 6. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY POC TESTING, 2018-2027 (USD MILLION)
TABLE 7. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY POC TESTING, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 8. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, 2018-2027 (USD MILLION)
TABLE 9. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 10. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY ELISA KITS, 2018-2027 (USD MILLION)
TABLE 11. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY ELISA KITS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 12. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY RAPID TEST KIT, 2018-2027 (USD MILLION)
TABLE 13. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY RAPID TEST KIT, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 14. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 15. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMMERCIAL LABS, 2018-2027 (USD MILLION)
TABLE 16. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMMERCIAL LABS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 17. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2027 (USD MILLION)
TABLE 18. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 19. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD MILLION)
TABLE 20. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY OFFLINE CHANNELS, 2018-2027 (USD MILLION)
TABLE 21. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY OFFLINE CHANNELS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 22. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY ONLINE CHANNELS, 2018-2027 (USD MILLION)
TABLE 23. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 24. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2027 (USD MILLION)
TABLE 25. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY HUMAN, 2018-2027 (USD MILLION)
TABLE 26. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY HUMAN, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 27. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY NON-HUMAN, 2018-2027 (USD MILLION)
TABLE 28. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY NON-HUMAN, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 29. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 30. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 31. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 32. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD MILLION)
TABLE 33. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2027 (USD MILLION)
TABLE 34. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 35. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 36. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 37. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD MILLION)
TABLE 38. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2027 (USD MILLION)
TABLE 39. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 40. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 41. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 42. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 43. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD MILLION)
TABLE 44. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2027 (USD MILLION)
TABLE 45. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 46. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 47. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 48. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET RANKING, BY KEY PLAYER, 2021
TABLE 49. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET SHARE, BY KEY PLAYER, 2021
TABLE 50. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET MERGER & ACQUISITION
TABLE 51. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 52. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 53. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET INVESTMENT & FUNDING
TABLE 54. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 55. NORTH AMERICA ANTI-MULLERIAN HORMONE TEST MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbexa Ltd.
  • Ansh Labs
  • BioMérieux SA
  • CTK Biotech, Inc.
  • Cusabio Technology LLC
  • Danaher Corporation
  • Doctorcall Limited
  • Eagle Biosciences, Inc.
  • Elabscience, Inc.
  • enQuire Bio, LLC
  • F. Hoffmann-La Roche AG
  • Fertility 2 U Ltd
  • Kamiya Biomedical Co
  • LifeSpan BioSciences, Inc.
  • London Gynaecology Ltd.
  • Monobind Inc.
  • Tosoh Corporation
  • Walk-In Lab, LLC

Methodology

Loading
LOADING...